Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
about
The Finnish evidence-based guideline for open-angle glaucoma.Prediction of functional loss in glaucoma from progressive optic disc damageAssessment of rates of structural change in glaucoma using imaging technologies.Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.Integrating event- and trend-based analyses to improve detection of glaucomatous visual field progressionProgression of visual field loss in untreated glaucoma patients and suspects in St Lucia, West Indies.Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma.Unsupervised machine learning with independent component analysis to identify areas of progression in glaucomatous visual fields.Biomarkers and surrogate endpoints in glaucoma clinical trials.Screening for primary open-angle glaucoma in the primary care setting: an update for the US preventive services task forceRetinal nerve fiber layer atrophy is associated with visual field loss over time in glaucoma suspect and glaucomatous eyesHow effectively does medical care achieve its purposes? Evaluation of peer-reviewed literature in ophthalmology related to wellness.The loss of visual function in glaucoma.Agreement between event-based and trend-based glaucoma progression analyses.The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis.The evidence base to select a method for assessing glaucomatous visual field progression.Combining structure and function to evaluate glaucomatous progression: implications for the design of clinical trials.Enhancement of Visual Field Predictions with Pointwise Exponential Regression (PER) and Pointwise Linear Regression (PLR).Risk factors for progressive visual field loss in primary open angle glaucoma.Comparison of event-based methods using optical coherence tomography and automated perimetry to detect the progression of glaucoma in patients with open-angle glaucoma.Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma.Comparison of disc analysis algorithms provided by cirrus OCT and stereo optic-disc photography in normal and open angle glaucoma patients.Non-parametric tests in detecting glaucoma progression.Examination of the performance of different pointwise linear regression progression criteria to detect glaucomatous visual field change.Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value.Evaluation of a Qualitative Approach for Detecting Glaucomatous Progression Using Wide-Field Optical Coherence Tomography Scans.Progression of visual field loss in open angle glaucoma in the Melbourne Visual Impairment ProjectNeutralizing Peripheral Refraction Eliminates Refractive Scotomata in Tilted Disc Syndrome
P2860
Q31134829-2C75CD05-5E66-497F-9BA6-C87DA678DBB1Q33687236-22A23E9D-2DAF-481E-931D-233977A0C5F2Q33787946-128050A1-561D-4099-A20D-C5650FB6E2F1Q34089805-84E0B1CC-78F9-479B-AB45-5614F0202D60Q34123546-BD0610FF-9C65-47A9-A8BD-A3ABB3734D94Q34135143-4D6DCBEE-DD0C-4E8D-84C2-13A9C07564A3Q34330962-A8A114E9-B1BA-44C4-BC49-448388774C4BQ34944081-02BACBF2-D23C-4125-A23F-602646238B24Q35699089-5EE998C5-5F11-485A-B22F-52A43C23E9C6Q35912696-065F39AC-0345-4270-9BC6-912AB15B861CQ36083707-3DE714B0-00BD-40C9-878F-66F2E0E092B6Q36476328-D124573E-8DDD-4211-825C-905E31B07418Q36481803-17850598-3F3E-4EBF-9E25-0AA8DE235013Q36856520-A9BC8957-BF76-42A4-9DEB-E2F33E83542EQ37005954-B7E29A41-97E6-455A-B6C9-864EB67EB240Q37799863-19969B0A-C90C-4C63-891F-46FD6C4C01ACQ37910990-B8122896-5218-4364-AAA6-98CA7561946CQ38065532-ADB93BEC-D040-467F-BB7E-F4F72C1D52AEQ38892382-0DEB54BC-6E6E-4939-8073-9BD82B377919Q42629163-74DE096A-99AC-4D00-8E30-270484C71F85Q42661255-EA80E2BF-4889-4A83-89F1-74A21BBE1969Q43267965-9786F86A-23E4-422E-BC30-FCC555B59780Q44738756-0ADE8DDF-1001-4022-98BA-930B90BA25C8Q47094493-F6D454BF-3B9B-4313-8AFA-BEAEC75F2B53Q51533499-3CABF6D2-1B0B-414E-910C-339E4AD1052EQ51983086-D78EF2FA-B95F-4245-95C8-FFE9E7FE542DQ55024290-5FFEC63A-35F4-4EC4-8B88-E349D7AB08B8Q57245044-9BBE9D23-E535-476E-968F-4C14986BCA45Q58703479-9D104CED-DA20-48C0-8D3D-AF03EE2B2E3F
P2860
Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Methodological variations in e ...... trials of glaucoma treatment.
@ast
Methodological variations in e ...... trials of glaucoma treatment.
@en
type
label
Methodological variations in e ...... trials of glaucoma treatment.
@ast
Methodological variations in e ...... trials of glaucoma treatment.
@en
prefLabel
Methodological variations in e ...... trials of glaucoma treatment.
@ast
Methodological variations in e ...... trials of glaucoma treatment.
@en
P2093
P1433
P1476
Methodological variations in e ...... trials of glaucoma treatment.
@en
P2093
P304
P356
10.1001/ARCHOPHT.117.9.1137
P407
P577
1999-09-01T00:00:00Z